Showing results (101-110 of 173) with videos related to

Sort By:
Pageof 18
Chest|January 29, 2025
Alpha-1-Antitrypsin Deficiency Targeted Testing and Augmentation Therapy: A Canadian Thoracic Society Meta-Analysis and Clinical Practice GuidelinePaul Hernandez, Yohan Bossé, Pam Bush, et al.
Respiratory Medicine|July 15, 2021
Asthma patients' and physicians' perspectives on the burden and management of asthmaKenneth R Chapman, Li An, Sinthia Bosnic-Anticevich, et al.
Chest|March 16, 2007
Tiotropium and simplified detection of dynamic hyperinflationArthur F Gelb, Colleen Flynn Taylor, Patricia A McClean, et al.
BMC Pulmonary Medicine|January 21, 2014
A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 studyKenneth R Chapman, Kai-Michael Beeh, Jutta Beier, et al.
Pulmonary Therapy|August 1, 2023
Triple Therapy with Mometasone/Indacaterol/Glycopyrronium or Doubling the ICS/LABA Dose in GINA Step 4: IRIDIUM AnalysesRichard N van Zyl-Smit, Huib A M Kerstjens, Jorge Maspero, et al.
Bioimpacts : BI|September 28, 2020
Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trialKhalil Ansarin, Ramin Tolouian, Mohammadreza Ardalan, et al.
BMC Clinical Pharmacology|October 6, 2010
Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized studyJames M Stocks, Mark L Brantly, Laurene Wang-Smith, et al.
The New England Journal of Medicine|May 17, 2016
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPDJadwiga A Wedzicha, Donald Banerji, Kenneth R Chapman, et al.
The Lancet. Respiratory Medicine|January 28, 2014
Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group studyMarc L Decramer, Kenneth R Chapman, Ronald Dahl, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
The Effect of Alpha-1 Proteinase Inhibitor on Biomarkers of Elastin Degradation in Alpha-1 Antitrypsin Deficiency: An Analysis of the RAPID/RAPID Extension TrialsShuren Ma, Yong Y Lin, Jerome O Cantor, et al.
Pageof 18